Canaccord Genuity Raises Price Target on Hologic (HOLX) Following 3Q Beat and FY15 Guidance Raise
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Hologic Announces Financial Results for Third Quarter of Fiscal 2015
July 29, 2015 4:02 PM EDTBEDFORD, Mass., July 29, 2015 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) announced today the Company's financial results for the fiscal third quarter ended June 27, 2015. Quarterly revenues of $693.9 million increased 9.7% on a reported basis, and 12.2% on a constant currency basis. GAAP earnings per share (EPS) of $0.10 increased 150%, while non-GAAP EPS of $0.43 increased 16.2%.
"Our third quarter financial results demonstrate the significant progress we have made in building a company that can grow sustainably on both the top and bottom lines," said Steve MacMillan, Hologic's Chairman, President and Chief Executive Officer. "Growth was led... More



